Medtronic Announces CE Mark of Evolut PRO+ TAVI System for Treatment of Symptomatic Severe Aortic Stenosis Patients in Europe
Medtronic Announces CE Mark of Evolut PRO+ TAVI System for Treatment of Symptomatic Severe Aortic Stenosis Patients in Europe As TAVI Patient Population Grows, PRO+ TAVI System Launches with Four Valve Sizes and Lowest Delivery Profile – Medtronic plc the global leader in medical technology, today announced CE Mark of the Evolut™ PRO+ TAVI System the newest-generation Medtronic TAVI system that builds off the proven self-expanding, supra-annular Evolut TAVI platform. The Evolut PRO+ TAVI System includes four valve sizes with an external … As TAVI Patient Population Grows, PRO+ TAVI Sy...
Source: investingnews.com